Lars Bode, Human milk oligosaccharides: Every baby needs a sugar mama, Glycobiology, Volume 22, Issue 9, September 2012, Pages 1147–1162,

Bode L. The functional biology of human milk oligosacchari-des. Early Hum Dev 2015; 91: 619-622

Thurl S, Munzert M, Boehm G et al. Systematic review of theconcentrations of oligosaccharides in human milk. Nutr Rev2017; 75: 920–933

Cole, Claire 2008 Oligosaccharides as anti-angiogenic agents
Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy humanmicrobiome. Genome Med 2016; 8: 51Zivkovic A, German J, Lebrilla C et al. Human milk glycobiomeand its impact on the infant gastrointestinal microbiota. ProcNatl Acad Sci U S A 2011, 108, 4653-4658

Kho ZY, Lal SK. The human gut microbiome–A potentialcontroller of wellness and disease. Front Microbiol 2018;9: 1835

Bergström A, Skov TH, Bahl MI, Roager HM, Christensen LB, Ejlerskov KT, Mølgaard C, Michaelsen KF, Licht TR. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol. 2014 May;80(9):2889-900. doi: 10.1128/AEM.00342-14. Epub 2014 Feb 28. PMID: 24584251; PMCID: PMC3993305

Elison E, Vigsnaes L, Rindom Krogsgaard L et al. Oral supple-mentation of healthy adults with 2′-O-fucosyllactose andlacto-N-neotetraose is well tolerated and shifts the intestinalmicrobiota. Br J Nutr 2016; 116: 1356–1368

Zhao, Gang 2’-Fucosyllactose Ameliorates Chemotherapy-Induced Intestinal Mucositis by Protecting Intestinal Epithelial Cells Against Apoptosis

Mortaz, Esmael Galactooligosaccharides (GOS) and 20 -fucosyllactose (20 -FL) can directly suppress growth of specific pathogenic microbes and impact phagocytosis of neutrophils

Ryan,Jennifer, 2021, Impact of 20 -Fucosyllactose on Gut Microbiota Composition in Adults with Chronic Gastrointestinal Conditions: Batch Culture Fermentation Model and Pilot Clinical Trial Findings

Irribaren, Christina 2021 The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome

Microbiota modulation to fight cancer Erez N. Baruch Science, 373 (6551), • DOI: 10.1126/science.abi9360
Prospecting Human Milk Oligosaccharides as a Defense Against Viral Infections Rebecca E. Moore1,#, Lianyan L. Xu1,#, Steven D. Townsend ACS Infect Dis. 2021 February 12; 7(2): 254–263 doi:10.1021/acsinfecdis.0c00807

Puccio G, Alliet P, Cajozzo C et al. Effects of Infant FormulaWith Human Milk Oligosaccharides on Growth and Morbidity.J Pediatr Gastroenterol Nutr 2017; 64: 624–631

Boehring K, Marriage B, Oliver J et al. Similar to those who arebreastfed, infants fed a formula containing 2ʹ-fucosyllactosehave lower inflammatory cytokines in a randomized control-led trial. J Nutr 2016; 146: 2559–2566

Yu Z-T, Nanthakumar N, Newburg D. The human milk oligo-saccharide 2′-fucosyllactose quenches Campylobacter jejuni-induced inflammation in human epithelial cells HEp-2 andHT-29 and in mouse intestinal mucosa. J Nutr 2016; 146:1980–1990

Coppa G V, Zampini L, Galeazzi T et al. Human milk oligosac-charides inhibit the adhesion to Caco-2 cells of diarrhealpathogens: Escherichia coli, Vibrio cholerae, and Salmonellafyris. Pediatr Res 2006; 59: 377–382

Morozov V, Hansman G, Hanisch F-G et al. Human milk oligo-saccharides as promising antivirals. Mol Nutr Food Res 2018; 62: 1700679
Urashima T, Taufik E, Fukuda K et al. Recent advances in stu-dies on milk oligosaccharides of cows and other domesticfarm animals. Biosci Biotechnol Biochem 2013; 77: 455–466

Albrecht S, Lane J, Mariño K et al. A comparative study of free oligosaccharides in the milk of domestic animals. Br J Nutr2014; 111: 1313–1328

Hanlon & Thorsrud 2014, Food Chem Toxicol 74:343-8; 2 (2-FL Safety in farm piglets)

Li et al 2014, ISME J 8:1609-20 (HMOs shorten RV-induced diarrhea in piglets)
Previous slide
Next slide